125 related articles for article (PubMed ID: 16897019)
1. [Long QT syndrome].
Zbinden S
Anaesthesist; 2006 Sep; 55(9):1006-7; author reply 1007-8. PubMed ID: 16897019
[No Abstract] [Full Text] [Related]
2. [Droperidol and cardiac arrhythmias].
Peramo Fernández F; González Fernández R; Maldonado Campos A
Rev Esp Anestesiol Reanim; 2003; 50(7):370. PubMed ID: 14552111
[No Abstract] [Full Text] [Related]
3. FDA advisory panel discusses droperidol concerns.
Young D
Am J Health Syst Pharm; 2004 Feb; 61(3):219-20, 222. PubMed ID: 14986550
[No Abstract] [Full Text] [Related]
4. FDA "black box" labeling.
Meyer RJ
Ann Emerg Med; 2003 Apr; 41(4):559-60. PubMed ID: 12658256
[No Abstract] [Full Text] [Related]
5. Droperidol, QT prolongation, and sudden death: what is the evidence?
Kao LW; Kirk MA; Evers SJ; Rosenfeld SH
Ann Emerg Med; 2003 Apr; 41(4):546-58. PubMed ID: 12658255
[TBL] [Abstract][Full Text] [Related]
6. Pro: The Food and Drug Administration Black box warning on droperidol is not justified.
Habib AS; Gan TJ
Anesth Analg; 2008 May; 106(5):1414-7. PubMed ID: 18420854
[No Abstract] [Full Text] [Related]
7. FDA response to droperidol black box warning editorials.
Rappaport BA
Anesth Analg; 2008 May; 106(5):1585. PubMed ID: 18420886
[No Abstract] [Full Text] [Related]
8. Droperidol--behind the black box warning.
Horowitz BZ; Bizovi K; Moreno R
Acad Emerg Med; 2002 Jun; 9(6):615-8. PubMed ID: 12045077
[No Abstract] [Full Text] [Related]
9. Droperidol's effect on QT interval.
Martinez JB; Moos DD; Dahlen LL
J Perianesth Nurs; 2006 Apr; 21(2):82-7. PubMed ID: 16600828
[TBL] [Abstract][Full Text] [Related]
10. Con: The black box warning on droperidol should not be removed (but should be clarified!).
Ludwin DB; Shafer SL
Anesth Analg; 2008 May; 106(5):1418-20. PubMed ID: 18420855
[No Abstract] [Full Text] [Related]
11. Reviewing case reports and the droperidol warning: FDA response.
Chang N; Simone A; Schultheis L; Rappaport B
Anesth Analg; 2003 Nov; 97(5):1542. PubMed ID: 14570686
[No Abstract] [Full Text] [Related]
12. Drug-induced prolongation of the QT interval: what's the point?
White PF; Abrao J
Anesthesiology; 2006 Feb; 104(2):386-7. PubMed ID: 16436877
[No Abstract] [Full Text] [Related]
13. Does low-dose droperidol administration increase the risk of drug-induced QT prolongation and torsade de pointes in the general surgical population?
Nuttall GA; Eckerman KM; Jacob KA; Pawlaski EM; Wigersma SK; Marienau ME; Oliver WC; Narr BJ; Ackerman MJ
Anesthesiology; 2007 Oct; 107(4):531-6. PubMed ID: 17893447
[TBL] [Abstract][Full Text] [Related]
14. [Droperidol and cardiac arrhythmias].
Gómez-Arnau JI
Rev Esp Anestesiol Reanim; 2003 May; 50(5):221-4. PubMed ID: 12833794
[No Abstract] [Full Text] [Related]
15. Sufficiency of data for resuming use of low-dose droperidol.
Wyllie AR; Carvalhana VV; Burry LD; Teresi JE
Am J Health Syst Pharm; 2008 Feb; 65(3):201. PubMed ID: 18216002
[No Abstract] [Full Text] [Related]
16. Black-box warning for droperidol surprises pharmacists.
Young D
Am J Health Syst Pharm; 2002 Mar; 59(6):494, 497, 502-4. PubMed ID: 11908241
[No Abstract] [Full Text] [Related]
17. FDA use of the black box warning: time for reevaluation as a safety tool.
Liang BA
J Clin Anesth; 2002 Dec; 14(8):561-3. PubMed ID: 12565112
[No Abstract] [Full Text] [Related]
18. Warnings strengthened on tranquilizer inapsine (Droperidol).
SoRelle R
Circulation; 2001 Dec; 104(25):E9061-2. PubMed ID: 11748130
[No Abstract] [Full Text] [Related]
19. Droperidol in the emergency department: is it safe?
Richards JR; Schneir AB
J Emerg Med; 2003 May; 24(4):441-7. PubMed ID: 12745049
[TBL] [Abstract][Full Text] [Related]
20. The black box warning.
Abourjaily HM; Rosenberg M
J Mass Dent Soc; 2002; 51(3):54-6. PubMed ID: 12380043
[No Abstract] [Full Text] [Related]
[Next] [New Search]
